FTO mediated glycolytic metabolism for papillary renal cell carcinoma immune evasion
Year: 2026
Type: article
Abstract: N6-methyladenosine (m6A) methylation is the predominant internal modification in eukaryotic mRNA, characterized by the methylation of adenosine at the nitrogen-6 position. A key m6A demethylase, the Fat Mass and Obesity-associated protein (FTO) play a significant role in metabolism. Renal cell carcinoma (RCC), particularly papillary RCC, is characterized by increased glucose uptake and a shift towards anaerobic glycolysis, commonly known as the “Warburg effect”. This study investigates the role of FTO in glycolytic reprogramming and immune evasion in RCC. FTO disruption resulted in a Lactate Dehydrogenase A (LDHA) expression downregulation, followed by lactate production reduction and CD8 + T cells activation. Furthermore, FTO pharmacological inhibition by DAC51 promoted CD8 + T cell activation, also resulting in increased apoptotic activity. These findings reveal a novel role for FTO in regulating tumor metabolism and immune escape in pRCC, highlighting its potential as a therapeutic target for cancer immunotherapy.
Source: Biomedicine & Pharmacotherapy
Institutions: Universidade do Porto, IPO Porto, Instituto de Ciências Biomédicas Albel Salazar, Research Institute Hospital 12 de Octubre, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, Josep Carreras Leukaemia Research Institute, LAQV Requimte, University of Aveiro, RISE - Health Research Network, Institució Catalana de Recerca i Estudis Avançats, Centro de Investigación Biomédica en Red, Centro de Investigación Biomédica en Red de Cáncer, Universitat de Barcelona
Language: English
Topic: RNA modifications and cancer
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $3,610
OpenAlex ID: W7224996850
